Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Wagner

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Pharmaceutical Education|March 23, 2022
Feeding the Soul via Creation of a Suborganization to Promote a Sense of CommunityCaitlin M Gibson, Suzanne Larson, Erin M Behnen, et al.
Infectious Diseases and Therapy|October 24, 2017
Time-Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis PatientsHana Rac, Kayla R Stover, Jamie L Wagner, et al.
The Journal of Surgical Research|August 24, 2020
Does the Addition of Breast MRI Add Value to the Diagnostic Workup of Invasive Lobular Carcinoma?Amanda L Amin, Stephen Sack, Kelsey E Larson, et al.
Infection Control and Hospital Epidemiology|May 14, 2016
Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption MetricsNathaniel J Rhodes, Jamie L Wagner, Elise M Gilbert, et al.
Jac-Antimicrobial Resistance|March 23, 2023
Penicillin-allergy delabelling resources for clinicians practicing in resource-limited settings: a full educational resource review of the grey literatureMary L Staicu, Meghan N Jeffres, Bruce M Jones, et al.
Pharmacy (Basel, Switzerland)|November 29, 2021
Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant EnterococciMary Joyce Wingler, Neel R Patel, S Travis King, et al.
The Nurse Practitioner|August 29, 2018
Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infectionsAllison M Bell, S Travis King, Katie E Barber, et al.
Infectious Diseases and Therapy|October 21, 2020
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay PatientsAdam G Pizzuti, E Yancy Murray, Jamie L Wagner, et al.
Diseases (Basel, Switzerland)|November 22, 2022
Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical CenterKylie Markovich, Mary Joyce B Wingler, Kayla R Stover, et al.
The Nurse Practitioner|April 14, 2017
Managing acute bacterial skin and skin structure infections: Focus on new lipoglycopeptidesAllison M Bell, S Travis King, Katie E Barber, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Pharmaceutical Education|March 23, 2022
Feeding the Soul via Creation of a Suborganization to Promote a Sense of CommunityCaitlin M Gibson, Suzanne Larson, Erin M Behnen, et al.
Infectious Diseases and Therapy|October 24, 2017
Time-Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis PatientsHana Rac, Kayla R Stover, Jamie L Wagner, et al.
The Journal of Surgical Research|August 24, 2020
Does the Addition of Breast MRI Add Value to the Diagnostic Workup of Invasive Lobular Carcinoma?Amanda L Amin, Stephen Sack, Kelsey E Larson, et al.
Infection Control and Hospital Epidemiology|May 14, 2016
Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption MetricsNathaniel J Rhodes, Jamie L Wagner, Elise M Gilbert, et al.
Jac-Antimicrobial Resistance|March 23, 2023
Penicillin-allergy delabelling resources for clinicians practicing in resource-limited settings: a full educational resource review of the grey literatureMary L Staicu, Meghan N Jeffres, Bruce M Jones, et al.
Pharmacy (Basel, Switzerland)|November 29, 2021
Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant EnterococciMary Joyce Wingler, Neel R Patel, S Travis King, et al.
The Nurse Practitioner|August 29, 2018
Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infectionsAllison M Bell, S Travis King, Katie E Barber, et al.
Infectious Diseases and Therapy|October 21, 2020
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay PatientsAdam G Pizzuti, E Yancy Murray, Jamie L Wagner, et al.
Diseases (Basel, Switzerland)|November 22, 2022
Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical CenterKylie Markovich, Mary Joyce B Wingler, Kayla R Stover, et al.
The Nurse Practitioner|April 14, 2017
Managing acute bacterial skin and skin structure infections: Focus on new lipoglycopeptidesAllison M Bell, S Travis King, Katie E Barber, et al.
Pageof 11